Lupin surges as its arm to acquire 100% stake in Southern Cross Pharma Pty
Lupin is currently trading at Rs. 1114.30, up by 28.65 points or 2.64% from its previous closing of Rs. 1085.65 on the BSE. The scrip opened at Rs.…
Lupin is currently trading at Rs. 1114.30, up by 28.65 points or 2.64% from its previous closing of Rs. 1085.65 on the BSE. The scrip opened at Rs.…
CSIR-CDRI, Lucknow is committed to support Pharma Cluster in Uttar Pradesh and has tied up with UP-based Marc Laboratories Pvt. Ltd., India,…
Union Minister of Chemicals and Fertilizers Shri. D.V. Sadananda Gowda has said that his Department of Pharmaceuticals has taken several measures to…
Strides Pharma Science’s step-down wholly owned subsidiary — Strides Pharma Global Pte, Singapore has entered into an exclusive product development, licensing and…
Glenmark Pharmaceuticals is planning to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision…
Glenmark Pharmaceuticals has launched of Nourkrin in Russia. Nourkrin is a globally renowned, clinically-proven proteoglycan replacement formula, for addressing one of the…
Biocon has moved up in the Top 10 Global Biotech Employers ranking for 2018 and continues to be the only company from…